These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 9986878)
21. Comparative resistance of Candida albicans clinical isolates to fluconazole and itraconazole in vitro and in vivo in a murine model. Valentin A; Le Guennec R; Rodriguez E; Reynes J; Mallie M; Bastide JM Antimicrob Agents Chemother; 1996 Jun; 40(6):1342-5. PubMed ID: 8725998 [TBL] [Abstract][Full Text] [Related]
22. Can we prevent azole resistance in fungi? Denning DW Lancet; 1995 Aug; 346(8973):454-5. PubMed ID: 7637473 [No Abstract] [Full Text] [Related]
23. [Itraconazole suspension in the treatment of HIV-infected patients with fluconazole-resistant oropharyngeal candidiasis and esophagitis]. Eichel M; Just-Nübling G; Helm EB; Stille W Mycoses; 1996; 39 Suppl 1():102-6. PubMed ID: 8767280 [TBL] [Abstract][Full Text] [Related]
24. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China. Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443 [TBL] [Abstract][Full Text] [Related]
25. Unresponsive HIV-related oro-oesophageal candidosis--an evaluation of two new in-vitro azole susceptibility tests. Cartledge JD; Midgley J; Petrou M; Shanson D; Gazzard BG J Antimicrob Chemother; 1997 Oct; 40(4):517-23. PubMed ID: 9372421 [TBL] [Abstract][Full Text] [Related]
26. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans. Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134 [TBL] [Abstract][Full Text] [Related]
27. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A; J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125 [TBL] [Abstract][Full Text] [Related]
28. In vitro susceptibility of 545 isolates of Candida spp. to four antifungal agents. Arias A; Arévalo MP; Andreu A; Rodríguez C; Sierra A Mycoses; 1994; 37(7-8):285-9. PubMed ID: 7739661 [TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. Swinne D; Raes-Wuytack C; Van Looveren K; Desmet P Mycoses; 1999; 42(4):231-7. PubMed ID: 10424089 [TBL] [Abstract][Full Text] [Related]
31. [25S rDNA genotype and antifungal susceptibility of vaginal Candida albicans]. Zhang X; Liu ZH Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):279-84. PubMed ID: 27116986 [TBL] [Abstract][Full Text] [Related]
32. [Comparison of three antifungal susceptibility testing methods for the in vitro testing of Candida isolates from patients with HIV infection]. Ruhnke M; Schmidt-Westhausen A; Trautmann M Mycoses; 1996; 39 Suppl 2():47-50. PubMed ID: 9198745 [TBL] [Abstract][Full Text] [Related]
33. Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations. Pelletier R; Peter J; Antin C; Gonzalez C; Wood L; Walsh TJ J Clin Microbiol; 2000 Apr; 38(4):1563-8. PubMed ID: 10747144 [TBL] [Abstract][Full Text] [Related]
34. Torulopsis glabrata: azole susceptibilities by microdilution colorimetric and macrodilution broth assays. Tiballi RN; Zarins LT; He X; Kauffman CA J Clin Microbiol; 1995 Oct; 33(10):2612-5. PubMed ID: 8567892 [TBL] [Abstract][Full Text] [Related]
35. Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients. Wong-Beringera A; Hindler J; Brankovic L; Muehlbauer L; Steele-Moore L Diagn Microbiol Infect Dis; 2001 Jan; 39(1):25-31. PubMed ID: 11173188 [TBL] [Abstract][Full Text] [Related]
36. Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection. Tumbarello M; Caldarola G; Tacconelli E; Morace G; Posteraro B; Cauda R; Ortona L J Antimicrob Chemother; 1996 Oct; 38(4):691-9. PubMed ID: 8937963 [TBL] [Abstract][Full Text] [Related]
37. Azole resistance in neonatal intensive care units in Argentina. Giusiano G; Mangiaterra M; Rojas F; Gómez V J Chemother; 2005 Jun; 17(3):347-50. PubMed ID: 16038532 [TBL] [Abstract][Full Text] [Related]